Symptons are always have been cold, tired, joint and muscle pain worse in fingers, I took Vioxx before it was removed , high blood pressure , tinnitus, completely deaf over 2,500 cycles in both ears. Hearing aids made no difference. Dentist last month couldn't freeze my gums with 2 needles of Carbocaine.
7mm nodule on thyroid. Blood tests TSH 2.15 ( range .465 to 4.68 ) FT4 11.17 ( range 10 to 28.2 ) Total T3 2.02 ( range .92 to 2.
PRINCETON, N.J., Aug 12, 2010 /PRNewswire via COMTEX News Network/ -- Pharmasset, Inc. (Nasdaq: VRUS) has received fast track designation from the U.S. Food and Drug Administration (FDA) for PSI-7977 for the treatment of chronic hepatitis C virus (HCV) infection. PSI-7977 is an oral uridine nucleotide analog polymerase inhibitor of HCV.
Methods
We used individual patient data from all randomised trials of daily aspirin versus no aspirin with mean duration of scheduled trial treatment of 4 years or longer to determine the effect of allocation to aspirin on risk of cancer death in relation to scheduled duration of trial treatment for gastrointestinal and non-gastrointestinal cancers. In three large UK trials, long-term post-trial follow-up of individual patients was obtained from death certificates and cancer registries.
Only 375 people are taking part in this BOC trial worldwide,BTW....its the NON-NAIVE trial,meaning its for non or slow responders....i beleive there is a trial being done for naive patients at the same time...if i heard my nurse correctly today.
2.Only 10 people in my trial study hospital are doing the trial.
Wonderful news! You must be sooo relieved to finally have those numbers back up and to be able to start tx. Congrats.
(ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel oral biotherapeutics for disorders associated with the microbiome, today announced initiation of a Phase 1a/1b clinical trial of ABI-H0731, its initial Core protein Allosteric Modifier (CpAM) for the treatment of chronic HBV.
The Phase 1a study will assess the safety, tolerability and pharmacokinetics of ABI-H0731 in healthy volunteers.
Just received the call that let me know that I'm in a 24 week Lambda interferon and ribavairin trial. Meds start the end of next week. I'll be glad to give updates to the experience or answer any questions that I can.
Have either 8 or 14 weeks left on my trial. Feel great most of the time. This new format has me all mixed up !!!!
I don't have a firm start date on this trial, but I see there is a person who just finished the 24 hour arm who just got a SVR4. This means an "official" SVR12 is still a few months away.
Factor in that these types of results are sometimes saved for liver conferences and one may not see results until even later.
At times companies will give out preliminary results, so one does not know when one will see the results revealed, even if they are preliminary or incomplete results.
//seekingalpha.
Recommended
